Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	92	73	67	164	132	119
Market Cap Growth	79.14%	8.31%	-58.91%	23.85%	11.02%	248.26%
Enterprise Value	102	87	54	134	117	103
PE Ratio	-	-2.25	-2.05	436.39	-7.28	-3.88
PS Ratio	10.88	8.88	50.80	5.55	16.78	54.92
PB Ratio	-5.24	-4.59	6.36	4.32	15.12	10.70
P/FCF Ratio	-5.58	-3.67	-4.95	-15.29	-10.06	-4.40
P/OCF Ratio	-6.09	-4.03	-5.04	-15.29	-10.10	-4.41
EV/Sales Ratio	12.06	10.59	41.01	4.54	14.81	47.30
EV/EBITDA Ratio	-3.56	-2.69	-1.66	242.46	-6.48	-3.36
EV/EBIT Ratio	-3.55	-2.68	-1.65	357.24	-6.42	-3.34
EV/FCF Ratio	-6.07	-4.37	-4.00	-12.51	-8.87	-3.79
Debt / Equity Ratio	-2.08	-2.70	3.32	0.02	0.23	0.57
Debt / EBITDA Ratio	-1.30	-1.33	-1.07	1.22	-0.11	-0.21
Debt / FCF Ratio	-2.21	-2.16	-2.59	-0.06	-0.15	-0.24
Quick Ratio	5.94	4.27	8.34	8.71	1.76	2.11
Current Ratio	6.07	4.42	8.54	9.08	1.82	2.31
Asset Turnover	0.23	0.22	0.03	0.93	0.40	0.07
Return on Equity (ROE)	251.80%	418.70%	-153.10%	1.60%	-210.40%	-246.60%
Return on Assets (ROA)	-94.70%	-85.30%	-75.80%	1.20%	-91.60%	-102.50%
Return on Capital (ROIC)	-114.57%	-91.71%	-66.01%	-1.62%	-169.51%	-175.17%
Earnings Yield	-38.04%	-44.49%	-48.87%	0.23%	-13.74%	-25.78%
FCF Yield	-22.29%	-27.27%	-20.19%	-6.54%	-9.94%	-22.70%
Buyback Yield / Dilution	-14.20%	-2.66%	-0.50%	-28.81%	-21.84%	-24.20%
Total Shareholder Return	-14.20%	-2.66%	-0.50%	-28.81%	-21.84%	-24.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).